Article Details

APhA 2025: GLP-1 Receptor Agonists vs SGLT2 Inhibitors Show Varied Benefit for ...

Retrieved on: 2025-03-23 15:30:34

Tags for this article:

Click the tags to see associated articles and topics

APhA 2025: GLP-1 Receptor Agonists vs SGLT2 Inhibitors Show Varied Benefit for .... View article details on hiswai:

Excerpt

The American Diabetes Association (ADA) guidelines now prioritize CV and renal health over simply managing A1c levels, and GLP-1s have demonstrated ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo